Skip Content
You are currently on the new version of our website. Access the old version .

Pharmaceuticals, Volume 7, Issue 3

2014 March - 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Article
  • Open Access
79 Citations
10,715 Views
13 Pages

Folate Receptor Targeted Alpha-Therapy Using Terbium-149

  • Cristina Müller,
  • Josefine Reber,
  • Stephanie Haller,
  • Holger Dorrer,
  • Ulli Köster,
  • Karl Johnston,
  • Konstantin Zhernosekov,
  • Andreas Türler and
  • Roger Schibli

13 March 2014

Terbium-149 is among the most interesting therapeutic nuclides for medical applications. It decays by emission of short-range α-particles (Eα = 3.967 MeV) with a half-life of 4.12 h. The goal of this study was to investigate the anticancer efficacy...

  • Article
  • Open Access
18 Citations
8,325 Views
14 Pages

Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor

  • Linjing Mu,
  • Roger Slavik,
  • Adrienne Müller,
  • Kasim Popaj,
  • Stjepko Čermak,
  • Markus Weber,
  • Roger Schibli,
  • Stefanie D. Krämer and
  • Simon M. Ametamey

6 March 2014

Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and therefore plays an important role in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis, amyotrophic lateral sclerosis and Alzh...

  • Review
  • Open Access
61 Citations
13,189 Views
28 Pages

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy

  • Wiebke Sihver,
  • Jens Pietzsch,
  • Mechthild Krause,
  • Michael Baumann,
  • Jörg Steinbach and
  • Hans-Jürgen Pietzsch

5 March 2014

The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody cetuximab has been approved alone or in combination with: (a) che...

  • Review
  • Open Access
315 Citations
22,683 Views
46 Pages

Antimicrobial Peptides from Fish

  • Jorge A. Masso-Silva and
  • Gill Diamond

3 March 2014

Antimicrobial peptides (AMPs) are found widely distributed through Nature, and participate in the innate host defense of each species. Fish are a great source of these peptides, as they express all of the major classes of AMPs, including defensins,...

  • Review
  • Open Access
113 Citations
14,969 Views
28 Pages

27 February 2014

Host defense peptides (HDPs) are an important first line of defense with antimicrobial and immunomoduatory properties. Because they act on the microbial membranes or host immune cells, HDPs pose a low risk of triggering microbial resistance and there...

  • Review
  • Open Access
61 Citations
14,779 Views
14 Pages

27 February 2014

Defensins are the most widespread antimicrobial peptides characterised in insects. These cyclic peptides, 4–6 kDa in size, are folded into α-helical/β-sheet mixed structures and have a common conserved motif of three intramolecular disulfide bridges...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247